A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

The trial was retrospectively registered with the Institutional Review Board of ALMA RES IVF Center, trial number n°2/2024.

Authors

Institutions

Publication Details

Journal
Health Economics Review
Published
2025-03-15
DOI
https://doi.org/10.1186/s13561-025-00609-8
Citations
2
Primary Topic
Ovarian function and disorders
Type
article
Field-Weighted Citation Impact
3.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

Gabriele Bilotta, Michele Russo, Vittorio Unfer, Maria Salomè Bezerra Espinola et al.
2 citations
Health Economics Review
Ovarian function and disorders
3.40
article

A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

Gabriele Bilotta, Michele Russo, Vittorio Unfer, Maria Salomè Bezerra Espinola, Samuel H. Myers, Cesare Aragona
article en
2 citations

Abstract

The trial was retrospectively registered with the Institutional Review Board of ALMA RES IVF Center, trial number n°2/2024.

Health Economics ReviewVol. 15(1)
Centro Studi GISED (IT), Sapienza University of Rome (IT)
Good health and well-being
Openalex Percentile: Top 10%
Ovarian function and disorders
3.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.